195 related articles for article (PubMed ID: 28430999)
1. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
2. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
[No Abstract] [Full Text] [Related]
5. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
[TBL] [Abstract][Full Text] [Related]
6. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
8. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
[TBL] [Abstract][Full Text] [Related]
9. Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection.
Ogawa Y; Hasebe R; Ohnuma T; Sano S; Mitsui H; Shimada S; Ishihara H; Sakagami T; Kawamura T
Eur J Dermatol; 2019 Jun; 29(3):339-341. PubMed ID: 31251217
[No Abstract] [Full Text] [Related]
10. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
[TBL] [Abstract][Full Text] [Related]
11. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
12. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
Furuya H; Ikeda K; Miyachi K; Nakamura K; Suzuki K; Furuta S; Tamachi T; Hirose K; Sakagami T; Nakajima H
Rheumatology (Oxford); 2017 Jul; 56(7):1241-1243. PubMed ID: 28371927
[No Abstract] [Full Text] [Related]
13. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Mycobacterium genavense Infection in Patient with Adult-Onset Immunodeficiency.
Asakura T; Namkoong H; Sakagami T; Hasegawa N; Ohkusu K; Nakamura A
Emerg Infect Dis; 2017 Jul; 23(7):1208-1210. PubMed ID: 28628454
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
Kacar M; Cortes-Acevedo P; Patel V; Carter C; Hughes P; McGann HP; Gkrania-Klotsas E; Baxendale HE; Barcenas-Morales G; Doffinger R; Savic S
J Clin Immunol; 2021 Oct; 41(7):1531-1535. PubMed ID: 34309742
[No Abstract] [Full Text] [Related]
17. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
Tanimizu M; Mizuno K; Hashimoto M
Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
[TBL] [Abstract][Full Text] [Related]
20. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
